Clinical Trial Update: A Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Breast Cancer

View source ↗

Summary

A pilot study evaluating a micro-organosphere drug screen platform to guide care in advanced breast cancer was terminated, leaving the platform's clinical utili…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Duke University | Conditions: Advanced Breast Cancer | Status: TERMINATED